AI Analysis – Experimental
House Bills 4544-46 establish a Prescription Drug Affordability Board and Stakeholder Council in Michigan to review high-cost prescription drugs, set upper payment limits when necessary, and promote transparency and affordability in drug pricing.
Introduced in the House
June 3, 2025
Introduced
by
Rep. Denise Mentzer (D-61)
and 34 co-sponsors
Co-sponsored by Reps.
Matt Longjohn (D-40), Sharon MacDonell (D-56), Joey Andrews (D-38), Noah Arbit (D-20), Dylan Wegela (D-26), Reggie Miller (D-31), Morgan Foreman (D-33), Stephen Wooden (D-81), Helena Scott (D-8), Jason Hoskins (D-18), Jason Morgan (D-23), Carrie Rheingans (D-47), Tonya Myers Phillips (D-7), Erin Byrnes (D-15), Phil Skaggs (D-80), Tyrone Carter (D-1), Jimmie Wilson (D-32), Jasper Martus (D-69), Amos O’Neal (D-94), Cynthia Neeley (D-70), Regina Weiss (D-5), Emily Dievendorf (D-77), Jennifer Conlin (D-48), Kelly Breen (D-21), Kara Hope (D-74), Veronica Paiz (D-10), Donavan McKinney (D-11), Julie Brixie (D-73), Betsy Coffia (D-103), Stephanie Young (D-16), Carol Glanville (D-84), Will Snyder (D-87), Natalie Price (D-6) and Mike McFall (D-14)
Referred to the Committee on Government Operations
